Registration Now Open for BOS Events 2024!

Bio2Business Ltd is delighted to open registration for BOS Events 2024 which includes: BOS Basel 2024, which will take place on the 19th and 20th of June at Congress Centre Basel; and BOS Manchester 2024, which will take place on the 26th and 27th of November at Manchester Central.

The focus of these events is partnerships in R&D outsourcing with the primary scope being development-stage CMC outsourcing of Small Molecules, Biologics and New Therapeutic Entities.

We continue to evaluate the opportunity for virtual events during 2024. We look forward to welcoming you and your colleagues to BOS Events 2024! Please contact the Bio2Business team for further details.

Featured Company (BOS Basel 2023)

Quotient Sciences
Quotient Sciences is a drug development and manufacturing accelerator providing integrated programs and tailored services across the entire development pathway. Cutting through silos across a range of drug development capabilities, we save precious time and money in getting drugs to patients. Everything...
View profile

Featured Speaker (BOS Basel 2023)

Deploying Appropriate Spending on Analytical Testing To Avoid Wasting Resources?

Dr Gerald Gellermann, Associate Director, Novartis

ABSTRACT: Molecule and process characterisation are key enables for defining a robust and lean commercial control strategy. Having the risk of an attribute to patient safety and molecule efficacy in focus, a balance needs to be found between success rate of the therapy to make it to the market and phase appropriate investment in analytical method development to gain sufficient molecule and process understanding.
Click here to Read More